Ventrus Biosciences Announces Pricing of Its Initial Public Offering

NEW YORK, Dec. 16, 2010 (GLOBE NEWSWIRE) — Ventrus Biosciences Inc. (“Ventrus”) (Nasdaq:VTUS), a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced the pricing of its initial public offering of 2,900,000 shares at .00 per share. The shares are expected to begin trading tomorrow, December 17, 2010 on the Nasdaq Capital Market [...] http://bit.ly/eoKqaC